Power Life Sciences Inc.
This study is observational, meaning that it does not include any interventions or new treatments. As a result, there may not be an immediate benefit for the patient with gastric cancer. However, the data collected from this trial can contribute to a better understanding of the factors that affect withdrawal and enrolment rates in gastric cancer clinical trials, and may ultimately lead to improved patient outcomes in the future.
Gastric Cancer
| Study Type : | Observational |
| Estimated Enrollment : | 500 participants |
| Official Title : | An Observational Study Evaluating The Experiences of Gastric Cancer Patients In Clinical Trials |
| Actual Study Start Date : | February 2024 |
| Estimated Primary Completion Date : | February 2025 |
| Estimated Study Completion Date : | February 2026 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.